Five-Year Summary, 7/2004 to 6/2009
Oklahoma
Women receiving an NBCCEDP-funded Pap test = 17,553
Five-Year Summary, 7/2004 to 6/2009
Oklahoma
Women receiving an NBCCEDP-funded Pap test = 17,553
Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2010 submission of the NBCCEDP Minimum Data Elements (MDE).
National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.
| Women Served through the NBCCEDP Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Women served* | 24,271 |
| Women screened** | 24,193 |
| Women receiving mammography | 11,459 |
| Women receiving Pap tests | 17,553 |
|
Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category. * Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure. ** Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test). Data Source: April 2010 submission of NBCCEDP Minimum Data Elements (MDE) |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2004 to 6/2009 Oklahoma Women receiving an NBCCEDP-funded Pap test = 17,553 |
|
Distribution by Age Five-Year Summary, 7/2004 to 6/2009 Oklahoma Women receiving an NBCCEDP-funded Pap test = 17,553 |
| See text description of these graphs. |
|
Cervical Cancer Screening Results and Outcomes Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Pap tests provided | 20,266 |
| Pap tests with abnormal results* | 582 |
| Percentage of Pap tests with abnormal results | 2.9 |
| Age-adjusted percentage** | 2.4 |
| Cervical cancers or cancer precursor lesions detected*** | 263 |
| CIN-1 or LSIL | 149 |
| CIN-2 or worse**** | 114 |
| Rate of CIN-2 or worse detected per 1,000 Pap tests**** | 5.6 |
| Age-adjusted rate per 1,000 Pap tests** | 4.9 |
|
* Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer. ** Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000. *** Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)-1, CIN-2, CIN-3, carcinoma in situ (CIS), and invasive cervical cancer. **** Includes HSIL, CIN-2, CIN-3, CIS, and invasive cervical cancer. Table includes only NBCCEDP-funded Pap tests. An additional 39 women, not included above, were diagnosed with LSIL, HSIL, CIN-1, CIN-2, CIN-3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source. |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2004 to 6/2009 Oklahoma  Women receiving an NBCCEDP-funded mammogram = 11,459 |
|
Distribution by Age Five-Year Summary, 7/2004 to 6/2009 Oklahoma  Women receiving an NBCCEDP-funded mammogram = 11,459 |
| See text description of these graphs. |
|
Breast Cancer Screening Results and Outcomes Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Mammograms provided | 16,400 |
| Abnormal mammograms* | 2,368 |
| Percentage of abnormal mammograms | 14.4 |
| Age-adjusted percentage** | 14.8 |
| Breast cancers detected*** | 122 |
| Rate of breast cancers detected per 1,000 mammograms | 7.4 |
| Age-adjusted rate per 1,000 mammograms** | 7.9 |
|
* Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required). ** Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000. *** Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS). Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 103 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source. |
|
|
Distribution by Race/Ethnicity Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Race | Percentage |
| White | 61.0 |
| Black | 9.7 |
| Asian/Pacific Islander | 1.5 |
| American Indian/Alaska Native | 5.3 |
| Multiracial | 0.1 |
| Hispanic | 22.2 |
| Unknown | 0.1 |
| Women receiving an NBCCEDP-funded Pap test = 17,553 | |
| Distribution by Age Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Age | Percentage |
| <30 | 11.3 |
| 30–39 | 25.8 |
| 40–49 | 26.8 |
| 50–64 | 35.4 |
| 65+ | 0.8 |
| Unknown | 0.0 |
| Women receiving an NBCCEDP-funded Pap test = 17,553 | |
Return to the Cervical Cancer Screening section
| Distribution by Race/Ethnicity Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Race | Percentage |
| White | 62.2 |
| Black | 11.2 |
| Asian/Pacific Islander | 1.3 |
| American Indian/Alaska Native | 5.4 |
| Multiracial | 0.1 |
| Hispanic | 19.5 |
| Unknown | 0.3 |
| Women receiving an NBCCEDP-funded mammogram = 11,459 | |
| Distribution by Age Five-Year Summary, 7/2004 to 6/2009 Oklahoma |
|
|---|---|
| Age | Percentage |
| <40 | 1.6 |
| 40–49 | 18.7 |
| 50–64 | 77.9 |
| 65+ | 1.8 |
| Unknown | 0.0 |
| Women receiving an NBCCEDP-funded mammogram = 11,459 | |